Fundz

Poseida Therapeutics, Inc. reported raising $23 Million in an initial SEC Form D filing, from an offering of $36 Million

PRIVATEDec 24, 2015

Amount Raised

$23 Million

$23 Million sold, per SEC Form D (first sale Dec 24, 2015)

Round Type

Venture

San DiegoBiotechnologyHealth CareTherapeutics

Who to call at Poseida Therapeutics, Inc., and when

A new round usually means Poseida Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Poseida Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Poseida Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Poseida Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Poseida Therapeutics, Inc.

Location

9390 Towne Centre Drive

San Diego, California, United States

About

Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies. The Company has formed a global strategic collaboration with Roche to unlock the promise of cell therapies for patients. Learn more at www.poseida.com and connect with us on Twitter and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Poseida Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Poseida Therapeutics, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Poseida Therapeutics, Inc.'s next move

See what Strategic adds

Poseida Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.